🔎 Trials Near Me

Home › Kidney Cancer (Renal Cell Carcinoma) › Colorado

Kidney Cancer (Renal Cell Carcinoma) clinical trials in Colorado

15 studies for Kidney Cancer (Renal Cell Carcinoma) are looking for participants at sites in Colorado.

Cities in Colorado

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Rocky Mountain Regional VA Medical Center, Aurora
  • UCHealth University of Colorado Hospital, Aurora
  • Penrose-Saint Francis Healthcare, Colorado Springs
  • and 15 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

  • University of Colorado Anschutz Medical Campus, Aurora
  • Rocky Mountain Cancer Centers, LLP, Lone Tree
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06234605

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  • Exelixis Clinical Site #87, Littleton
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT05176483

DESTINY-PANTUMOUR04

  • Research Site, Boulder
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

  • UCHealth University of Colorado Hospital, Aurora
  • UCHealth - Cherry Creek, Denver
  • Poudre Valley Hospital, Fort Collins
  • and 5 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05327686

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

  • Rocky Mountain Cancer Centers,LLP, Aurora
  • Clinical and Translational Research Center(CTRC), Aurora
  • University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP), Aurora
  • and 8 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07227415

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • University of Colorado, Aurora
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT05059444

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

  • UCHealth University of Colorado Hospital, Aurora
  • UCHealth Memorial Hospital Central, Colorado Springs
  • Memorial Hospital North, Colorado Springs
  • and 7 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06661720

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • Sarah Cannon Research Institute - Denver DDU, Denver
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT06582017

Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial

  • University of Colorado Anschutz Medical Campus, Aurora
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT06432036

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

  • Sarah Cannon Research Institute at HealthONE, Denver
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 8, 2026 · NCT06026410

Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus

  • University of Colorado Cancer Center, Aurora
  • Hilands Ranch Hospital, Highlands Ranch
  • Lone Tree Medical Center, Lone Tree
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT05969496

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

  • University of Colorado Cancer Center, Aurora
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT06362369

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

  • Sarah Cannon Research Institute at HealthONE, Denver
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 15, 2024 · NCT04787042

From ClinicalTrials.gov, data retrieved Oct 7, 2026. Each study sets its own eligibility; the study team decides who can join.